Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Capital Expenditures (2022 - 2026)

Alvotech's (ALVO) quarterly Capital Expenditures came in at -$27.9 million in Q2 2026, down 104.64% on a YoY basis from $600.5 million in Q2 2025, and down 290.2% quarter-over-quarter from -$7.1 million in Q1 2026.

Analysis

Alvotech (ALVO) Capital Expenditures (2022 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Capital Expenditures for 5 consecutive years, with -$27.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Capital Expenditures fell 104.64% year-over-year to -$27.9 million; the trailing twelve-month figure through Jun 2026 stood at -$62.7 million (up 39.9% YoY), and the FY2025 full-year result was -$64.5 million, down 20.14% from the prior year.
  • Capital Expenditures slipped to -$27.9 million in Q2 2026 per ALVO's latest filing, from -$7.1 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $19.6 million in Q2 2022 and bottomed at -$53.7 million in Q4 2024.
  • Historically, Capital Expenditures has averaged -$17.1 million across 5 years, with a median of -$13.7 million in 2024.
  • The widest YoY moves for Capital Expenditures: up 83.71% in 2025, down 469.85% in 2025.
  • Over 5 years, Capital Expenditures stood at -$37.9 million in 2022, then climbed by 12.27% to -$33.2 million in 2023, then tumbled by 61.46% to -$53.7 million in 2024, then soared by 83.71% to -$8.7 million in 2025, then slumped by 218.89% to -$27.9 million in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods registered -$27.9 million, -$7.1 million, and -$8.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 104.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 52.80 Mn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -36.19 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 30.70 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 77.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -27.87 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 3.05 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 8.59 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -27.87 Mn
Mar 31, 2026 -7.14 Mn
Dec 31, 2025 -8.74 Mn
Sep 30, 2025 -18.93 Mn
Jun 30, 2025 -13.62 Mn
Mar 31, 2025 -23.19 Mn
Dec 31, 2024 -53.66 Mn
Sep 30, 2024 -13.82 Mn
Jun 30, 2024 -6.20 Mn
Mar 31, 2024 -4.07 Mn
Dec 31, 2023 -33.23 Mn
Jun 30, 2023 -11.27 Mn
Dec 31, 2022 -37.88 Mn
Jun 30, 2022 19.57 Mn